Innovacyn Names Dr. Fred Ma as Chief Medical Officer

Share Article

Seasoned regulatory professional to help guide growth of Vetericyn and Puracyn brands.

As we continue the worldwide expansion of our Vetericyn and Puracyn brands, having Dr. Ma on board will be a tremendous asset.

Innovacyn Inc., a provider of human and animal healthcare products, today announced that Dr. Fred Ma has joined the company as chief medical officer. In this newly created position, Dr. Ma will be responsible for overall strategic planning and management of clinical, medical and regulatory affairs. He will also oversee quality assurance in compliance with FDA and international standards, and will help continue building Innovacyn’s quality management system.

“As we continue the worldwide expansion of our Vetericyn and Puracyn brands, having Dr. Ma on board will be a tremendous asset. His proven track record and extensive regulatory experience will help ensure that our products meet every quality and safety standard required by medical and regulatory agencies,” said Dave Mills, general manager of Innovacyn.

Prior to Innovacyn, Dr. Ma served as the founder, president and CEO of Medical Quality International, a consultancy that provides comprehensive regulatory compliance, quality assurance and business development services. Dr. Ma previously held executive posts at several pharmaceutical companies, including Johnson & Johnson, Cell Pathways and Gliatech Medical Inc. During his tenure at these companies, he was responsible for the clinical, medical and regulatory affairs for product development, as well as regulatory filing for FDA approvals and manufacturing processes. He led 28 successful product regulatory approvals (new drugs, medical devices and combination products) in the United States and worldwide.

Before his career in the pharmaceutical and medical device industries, Dr. Ma was a board-certified neurosurgeon and oncologist. He received an M.D. from Capital University of Medical Sciences in Beijing, a D.M.Sc. from Tokyo University, and a Ph.D. from Rutgers.

About Innovacyn Inc.

Based in Rialto, Calif., Innovacyn Inc. is a privately held company that provides premier human and animal healthcare products based on advanced scientific research. More than two million people and countless animals worldwide have benefited from the technology found in Innovacyn products. For more information about Innovacyn, visit To learn more about Innovacyn’s products for the human market, visit, and for animals, visit All Innovacyn products are made in the U.S.A.


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Debbie Pfeifer
(206) 669-3580
Email >
Visit website